C4 Therapeutics (CCCC) Research & Development (2019 - 2025)
Historic Research & Development for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $26.0 million.
- C4 Therapeutics' Research & Development fell 1837.11% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.8 million, marking a year-over-year increase of 300.05%. This contributed to the annual value of $110.6 million for FY2024, which is 600.56% down from last year.
- C4 Therapeutics' Research & Development amounted to $26.0 million in Q3 2025, which was down 1837.11% from $26.2 million recorded in Q2 2025.
- C4 Therapeutics' 5-year Research & Development high stood at $32.5 million for Q4 2024, and its period low was $20.5 million during Q1 2021.
- Moreover, its 5-year median value for Research & Development was $27.1 million (2025), whereas its average is $27.4 million.
- Per our database at Business Quant, C4 Therapeutics' Research & Development skyrocketed by 3451.43% in 2022 and then plummeted by 2241.24% in 2024.
- Over the past 5 years, C4 Therapeutics' Research & Development (Quarter) stood at $26.6 million in 2021, then grew by 15.45% to $30.7 million in 2022, then dropped by 0.85% to $30.4 million in 2023, then rose by 6.98% to $32.5 million in 2024, then dropped by 20.07% to $26.0 million in 2025.
- Its last three reported values are $26.0 million in Q3 2025, $26.2 million for Q2 2025, and $27.1 million during Q1 2025.